Page last updated: 2024-11-04

sulfamethoxypyridazine and Leprosy, Cutaneous

sulfamethoxypyridazine has been researched along with Leprosy, Cutaneous in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BETOURNE, C1
VALLIN, J1
GENTILINI, M1
HAYEM, F1
Constant-Desportes, M1
Guelpa-Lauras, CC1
Carolina, JC1
LĂ©oture, A1
Grosset, JH1
Sansarricq, H1

Other Studies

2 other studies available for sulfamethoxypyridazine and Leprosy, Cutaneous

ArticleYear
[LEPROMATOUS LEPROSY WITH HEPATIC LOCALIZATION].
    Bulletins et memoires de la Societe medicale des hopitaux de Paris, 1964, Mar-20, Volume: 115

    Topics: Biopsy; Blood Chemical Analysis; Face; Geriatrics; Hand; Humans; Leprosy; Leprosy, Lepromatous; Live

1964
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1991, Volume: 59, Issue:2

    Topics: Adult; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male;

1991